Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alla Skapenko

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Experimental Medicine|February 6, 2004
GATA-3 in human T cell helper type 2 developmentAlla Skapenko, Jan Leipe, Uwe Niesner, et al.
Annals of the Rheumatic Diseases|February 25, 2014
Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritisQihui Zhou, Sonja Haupt, Johannes T Kreuzer, et al.
Arthritis and Rheumatism|December 1, 2007
Treg cells suppress osteoclast formation: a new link between the immune system and boneMario M Zaiss, Roland Axmann, Jochen Zwerina, et al.
Scientific Reports|October 25, 2018
Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinasesAriane Hammitzsch, Liye Chen, Jelle de Wit, et al.
Annals of the Rheumatic Diseases|January 8, 2013
Activation of pregnane X receptor inhibits experimental dermal fibrosisChristian Beyer, Alla Skapenko, Alfiya Distler, et al.
Arthritis and Rheumatism|April 29, 2006
Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritisIryna Prots, Alla Skapenko, Jörg Wendler, et al.
Annals of the Rheumatic Diseases|May 20, 2011
Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritisJan Leipe, Markus A Schramm, Mathias Grunke, et al.
Thorax|August 7, 2017
Pulmonary CCR2<sup>+</sup>CD4<sup>+</sup> T cells are immune regulatory and attenuate lung fibrosis developmentKatrin Milger, Yingyan Yu, Eva Brudy, et al.
Annals of the Rheumatic Diseases|October 31, 2020
Correspondence to 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'Hendrik Schulze-Koops, Alla Skapenko, Andreas Krause, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2024
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case studyMarion Subklewe, Giulia Magno, Christina Gebhardt, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Experimental Medicine|February 6, 2004
GATA-3 in human T cell helper type 2 developmentAlla Skapenko, Jan Leipe, Uwe Niesner, et al.
Annals of the Rheumatic Diseases|February 25, 2014
Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritisQihui Zhou, Sonja Haupt, Johannes T Kreuzer, et al.
Arthritis and Rheumatism|December 1, 2007
Treg cells suppress osteoclast formation: a new link between the immune system and boneMario M Zaiss, Roland Axmann, Jochen Zwerina, et al.
Scientific Reports|October 25, 2018
Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinasesAriane Hammitzsch, Liye Chen, Jelle de Wit, et al.
Annals of the Rheumatic Diseases|January 8, 2013
Activation of pregnane X receptor inhibits experimental dermal fibrosisChristian Beyer, Alla Skapenko, Alfiya Distler, et al.
Arthritis and Rheumatism|April 29, 2006
Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritisIryna Prots, Alla Skapenko, Jörg Wendler, et al.
Annals of the Rheumatic Diseases|May 20, 2011
Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritisJan Leipe, Markus A Schramm, Mathias Grunke, et al.
Thorax|August 7, 2017
Pulmonary CCR2<sup>+</sup>CD4<sup>+</sup> T cells are immune regulatory and attenuate lung fibrosis developmentKatrin Milger, Yingyan Yu, Eva Brudy, et al.
Annals of the Rheumatic Diseases|October 31, 2020
Correspondence to 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'Hendrik Schulze-Koops, Alla Skapenko, Andreas Krause, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2024
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case studyMarion Subklewe, Giulia Magno, Christina Gebhardt, et al.
Pageof 6